Adding high-dose vitamin C to a cancer treatment regimen may double survival time, according to a clinical trial that tested this in pancreatic cancer patients.
Typically diagnosed in its advanced stages, pancreatic cancer has a poor prognosis and leaves patients with limited treatment options, with most surviving only eight months with standard chemotherapy.
“When we started the trial, we thought it would be a success if we got to 12 months survival, but we doubled overall survival to 16 months,” senior study author Dr. Joe Cullen, professor of surgery and radiation oncology at the University of Iowa, said in a press statement.
“The results were so strong … that we were able to stop the trial early.”…